“Fewer” physicians “would have to wait for permission to prescribe addiction treatment” medications “under new, bipartisan legislation being unveiled this week by two lawmakers on the House Energy and Commerce Committee,” STAT (11/18, Facher) reports. The new bill, as written by Representatives Paul Tonko (D-NY) and David McKinley (R-WV), would ban “the practice of ‘prior authorization,’ in which insurers require doctors to seek approval before they can proceed with a prescription or procedure,” in state “Medicaid programs for addiction treatment medicines like buprenorphine.” The measure “comes amid part of a broader movement to expand addiction treatment as the overdose crisis continues to claim roughly 70,000 American lives each year.” STAT adds, “In a 2017 survey conducted by the American Medical Association, 64% of physicians reported waiting at least a day for authorization to prescribe addiction” medications.
Related Links:
— “A new bill would let more doctors prescribe addiction treatments without waiting for insurers’ permission, ” Lev Facher, STAT, November 18, 2019